Euronext Brussels

Belgian indices

BEL 20 3 661,42 -1,04 %
BEL ALL-SHARE 12 877,86 -0,97 %
BEL MID INDEX 6 804,07 +0,08 %
BEL SMALL INDEX 8 849,54 -0,62 %
BEL CONTINUOUS 34 065,20 -0,97 %

EU indices

EURONEXT 100 1 459,20 -0,24 %
CLIMATE EUROPE 1 868,52 -0,25 %
LOW CARBON 100 160,80 -0,22 %
NEXT BIOTECH 2 126,69 -5,45 %
ESG 80 2 026,94 -0,16 %

Currency rates - Last and change

EUR / USD 1,08141 +0,09 %
EUR / GBP 0,85615 +0,04 %
EUR / JPY 162,69 +0,38 %
EUR / CHF 0,95774 +0,21 %
GBP / USD 1,26318 +0,04 %

Top performers Brussels

Caricamento in corso... Attendere.
Belgian indices
BEL 20
Chart
BEL ALL-SHARE
Chart
BEL CONTINUOUS
Chart
BEL MID INDEX
Chart
BEL SMALL INDEX
Chart
More Euronext Brussels

Learn more about our Brussels markets

Visit our Brussels page on Euronext.com and learn about the home to the BEL20. 

Euronext Brussels - Le Marquis
Company news
01 Mar 2024
08:15 CET
Bekaert - Mise à jour relative au Programme de Rachat d’Actions
01 Mar 2024
08:15 CET
Bekaert - Update over het Inkoopprogramma van Eigen Aandelen
01 Mar 2024
08:15 CET
Bekaert - Update on the Share Buyback Program
01 Mar 2024
07:45 CET
Belysse FY 2023 Resultaten
01 Mar 2024
07:44 CET
Belysse FY 2023 Results
01 Mar 2024
07:05 CET
bpost: fourth quarter 2023 results
01 Mar 2024
07:04 CET
bpost: fourth quarter 2023 results
01 Mar 2024
07:04 CET
bpost: fourth quarter 2023 results
01 Mar 2024
07:00 CET
Bekaert: Jaarresultaten 2023
01 Mar 2024
07:00 CET
Bekaert: 2023 Full Year Results
01 Mar 2024
07:00 CET
Bekaert: Résultats annuels 2023
29 Feb 2024
22:30 CET
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
29 Feb 2024
22:30 CET
Nyxoah Participera à la 34ème Oppenheimer Annual Healthcare MedTech & Services Conference
29 Feb 2024
18:16 CET
James Neuling appointed CEO of Belysse Group NV
29 Feb 2024
18:15 CET
James Neuling benoemd tot CEO van Belysse Group NV
29 Feb 2024
18:00 CET
Overeenkomst tussen Fluxys Belgium en de CREG over de billijke winstmarge
29 Feb 2024
18:00 CET
Agreement between Fluxys Belgium and the CREG on the fair margin
29 Feb 2024
18:00 CET
Accord entre Fluxys Belgium et la CREG sur la marge équitable
29 Feb 2024
11:42 CET
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
29 Feb 2024
09:09 CET
20240229 SHUR Full Year 2023 results February 29 2024
IPOs
SYENSQO
DMS IMAGING
DEME GROUP
MAZARO
ONWARD Medical